Intraperitoneal engineered Newcastle disease virus encoding interleukin-12 in combination with PD-1 blockade for therapy of ovarian cancer

Activity: Talk or presentation › Oral presentation

Period	Apr 2023
Held at	New York Obstetric Society (Podium Plenary)